CoChat
Sign Up
Cited by 28Renal Diseases and GlomerulopathiesChronic Kidney Disease and DiabetesLipid metabolism and disorders

A Case of Lipoprotein Glomerulopathy Successfully Treated with Probucol

Amenomori, Masaki, Haneda, Masakazu, Morikawa, Junichirou, Nishigaki, Itsurou, Maeda, Shiro, Hidaka, Hideki, Kikkawa, Ryuichi, Shigeta, Yukio·2008·Nephron
DOI 10.1159/000187897
Open this paper in CoChat — free account

Abstract

A 54-year-old woman presented proteinuria and severe hyperlipoproteinemia, She had type III hyperlipoproteinemia with the phenotype E2/2. Renal biopsy specimen revealed lipoprotein thrombi within the glomerular capillary lumina without tubulointerstitial lesion and deposition of IgA in the mesangium and peripheral capillary loops, indicating lipoprotein glomerulopathy with IgA nephropathy. Treatment with probucol resulted in the improvement of both hyperlipoproteinemia and proteinuria with the disappearance of the lipoprotein thrombi in the glomerular capillary without any change in the mesangial IgA deposition. The data suggest that probucol may be effective against the early stage of lipoprotein glomerulopathy with less lipoprotein thrombi and without tubulointerstitial damage.

Integrity signals

Registry

Crossref · 10.1159/000187897

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Worldwide, only 22 cases of LPG including this case have reported the results of more than one native kidney biopsy.

    “Worldwide, only 22 cases of LPG including this case have reported the results of more than one native kidney biopsy.14,15,29,32,44–49”

    From Lipoprotein Glomerulopathy, First Case Report from Canada (2022) · cites this paper as [44]

Cited by

Sorted by citations

Authors
Amenomori, M., Haneda, M., Morikawa, J., Nishigaki, I., Maeda, S., Hidaka, H., Kikkawa, R., & Shigeta, Y.
Affiliations
Shiga University of Medical Science (JP)
ORCID
Venue
Nephron
Publisher
S. Karger AG
Published
2008-12-17
Volume
67
Issue
1
Pages
109-113
ISSN
  • 1660-8151 (ISSN-L)
  • 2235-3186
DOI
10.1159/000187897
OpenAlex
W2031300353
Cited by
28
References
0
Citations by year
2025: 2 · 2022: 2 · 2019: 1 · 2013: 2 · 2012: 1
FWCI
1.87
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • The Nephron journals/Nephron journals (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords
lipoprotein glomerulopathy, probucol, type III hyperlipoproteinemia, hyperlipoproteinemia, proteinuria, IgA nephropathy, IgA deposition, glomerular capillaries, renal biopsy
MeSH terms
Female, Glomerulonephritis, IGA, Humans, Hyperlipoproteinemia Type III, Kidney Diseases, Lipids, Middle Aged, Probucol

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review